Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2015
[Diagnostic criteria of multiple myeloma]Hiroyuki HataLeukemia & Lymphoma|July 16, 2005
Bone lesions and macrophage inflammatory protein-1 alpha (MIP-1a) in human multiple myelomaHiroyuki HataGan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2006
[Management of bone lesions in multiple myeloma]Hiroyuki Hata, Hiroaki MitsuyaNihon Rinsho. Japanese Journal of Clinical Medicine|December 12, 2007
[Molecular mechanisms inhibiting proliferation of myeloma cells]Yoshitaka Kikukawa, Yutaka Okuno, Hiroyuki HataAnticancer Research|April 4, 2008
Induction of necrosis in human myeloma cells by kigamicinMiki Nakamura, Hiroyasu Esumi, Lu Jin, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 23, 2014
Complete remission achieved in a multiple myeloma patient with elevated serum KL-6 level by a combination regimen with bortezomib, cyclophosphamide, and dexamethasoneYutaka Okuno, Nao Nishimura, Kisato Nosaka, et al.International Journal of Oncology|September 3, 2010
Clarithromycin attenuates autophagy in myeloma cellsMiki Nakamura, Yoshitaka Kikukawa, Motohiro Takeya, et al.Journal of the Neurological Sciences|August 3, 2010
Successful treatment with rituximab and thalidomide of POEMS syndrome associated with Waldenstrom macroglobulinemiaYawara Kawano, Tatsuya Nakama, Hiroyuki Hata, et al.British Journal of Haematology|December 21, 2002
Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MMShima Uneda, Hiroyuki Hata, Fumihiko Matsuno, et al.Biochemical and Biophysical Research Communications|December 7, 2021
A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cellsYawara Kawano, Takayuki Sasano, Yuichiro Arima, et al.Pageof 7